Search research articles
Contact Us
Filters
Showing results (171-180 of 258) with videos related to
Page
of 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2005
Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
P Maroto, X García del Muro, J Aparicio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, et al.
Journal of Molecular Liquids
|
August 23, 2021
Structural deformability induced in proteins of potential interest associated with COVID-19 by binding of homologues present in ivermectin: Comparative study based in elastic networks models
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, et al.
Journal of the National Cancer Institute
|
June 7, 1995
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
J I Mayordomo, F Rivera, M T Díaz-Puente, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
October 24, 2022
[Patients with immunization against SARS-CoV-2 who have required hospital admission due to covid-19 pneumonia in a regional hospital (Sierrallana-Cantabria)]
P Hernández Martínez, P González Bores, S López Garrido, et al.
RSC Advances
|
September 15, 2023
Amidinoquinoxaline <i>N</i>-oxides: synthesis and activity against anaerobic bacteria
Nadia Gruber, Liliana Fernández-Canigia, Natalia B Kilimciler, et al.
Bone
|
April 9, 2025
Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)
Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Bone
|
August 7, 2025
Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477]
Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Redox Biology
|
August 13, 2024
A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma
M Sánchez-Ortega, A Garrido, C Cirauqui, et al.
British Journal of Cancer
|
March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
X Garcia del Muro, E Marcuello, J Gumá, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 258) with videos related to
Sort By:
Page
of 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2005
Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours
P Maroto, X García del Muro, J Aparicio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 2014
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
B Besse, A Adjei, P Baas, et al.
Journal of Molecular Liquids
|
August 23, 2021
Structural deformability induced in proteins of potential interest associated with COVID-19 by binding of homologues present in ivermectin: Comparative study based in elastic networks models
Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, et al.
Journal of the National Cancer Institute
|
June 7, 1995
Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors
J I Mayordomo, F Rivera, M T Díaz-Puente, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
October 24, 2022
[Patients with immunization against SARS-CoV-2 who have required hospital admission due to covid-19 pneumonia in a regional hospital (Sierrallana-Cantabria)]
P Hernández Martínez, P González Bores, S López Garrido, et al.
RSC Advances
|
September 15, 2023
Amidinoquinoxaline <i>N</i>-oxides: synthesis and activity against anaerobic bacteria
Nadia Gruber, Liliana Fernández-Canigia, Natalia B Kilimciler, et al.
Bone
|
April 9, 2025
Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)
Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Bone
|
August 7, 2025
Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477]
Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, et al.
Redox Biology
|
August 13, 2024
A potential therapeutic strategy based on acute oxidative stress induction for wild-type NRF2/KEAP1 lung squamous cell carcinoma
M Sánchez-Ortega, A Garrido, C Cirauqui, et al.
British Journal of Cancer
|
March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
X Garcia del Muro, E Marcuello, J Gumá, et al.
Page
of 26